FDA to speed up approvals of generic biologic medicines
Digest more
Oral and inhaled biologics are gaining R&D investment due to patient acceptance and potential for home administration, with ...
Innovent Biologics (SEHK:1801) just unveiled a partnership with Takeda to speed up global development and commercialization of next-generation cancer therapies. The collaboration features ...
Biologics, with their precision targeting, expand treatment options for a multitude of diseases - from cancer to autoimmune disorders. In 2023 alone, 10 antibody therapeutics received their first ...
Just-Evotec Biologics inked a contract with the federal government to develop monoclonal antibody (mAb)-based drug prototypes against orthopoxviruses, Evotec SE announced Wednesday. The deal with ...
Opinions expressed by Digital Journal contributors are their own. Bringing a new biologic drug from concept to clinic is a complex journey fraught with technical and regulatory hurdles. For ...
psoriatic arthritisin the hand Researchers assessed whether biologics reduce the incidence of psoriatic arthritis among patients with psoriasis. Switching from phototherapy to biologics may ...
SHANGHAI, Nov. 22, 2023 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced today that it has ...
Theriva Biologics (TOVX) announced that the company had become aware of unusual trading activity in its common stock on the NYSE American on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback